Correlation Between Carmat and Gensight Biologics

Can any of the company-specific risk be diversified away by investing in both Carmat and Gensight Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Carmat and Gensight Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Carmat and Gensight Biologics SA, you can compare the effects of market volatilities on Carmat and Gensight Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Carmat with a short position of Gensight Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Carmat and Gensight Biologics.

Diversification Opportunities for Carmat and Gensight Biologics

0.48

Correlation Coefficient

Carmat  Gensight Biologics

Very weak diversification

The 3 months correlation between Carmat and Gensight is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Carmat and Gensight Biologics SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gensight Biologics and Carmat is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Carmat are associated (or correlated) with Gensight Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gensight Biologics has no effect on the direction of Carmat i.e., Carmat and Gensight Biologics go up and down completely randomly.

Pair Corralation between Carmat and Gensight Biologics

Assuming the 90 days trading horizon Carmat is expected to under-perform the Gensight Biologics. In addition to that, Carmat is 1.12 times more volatile than Gensight Biologics SA. It trades about -0.14 of its total potential returns per unit of risk. Gensight Biologics SA is currently generating about -0.04 per unit of volatility. If you would invest  39.00  in Gensight Biologics SA on September 15, 2024 and sell it today you would lose (7.00) from holding Gensight Biologics SA or give up 17.95% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	98.48%
Values	Daily Returns

Carmat  vs.  Gensight Biologics SA

Carmat

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Carmat has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Gensight Biologics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Gensight Biologics SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Stock's basic indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

Pair Trading with Carmat and Gensight Biologics

The main advantage of trading using opposite Carmat and Gensight Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Carmat position performs unexpectedly, Gensight Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gensight Biologics will offset losses from the drop in Gensight Biologics' long position.

The idea behind Carmat and Gensight Biologics SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.